Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy

65Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Purpose: To determine the effects of desmopressin on coagulation and blood loss in patients undergoing elective partial hepatectomy. Methods: A randomized, controlled and double-blind study on 59 patients who received either 0.3 μg·kg-1 of desmopressin or an equal volume of normal saline (control) infused intravenously over 20 min after induction of general anesthesia. Results: There was an increase in plasma levels of factors VIII and von Willebrand after the infusion of study drug in both groups (P < 0.001). The activated partial thromboplastin time was shortened in Group D whereas prothrombin time was prolonged in Group C; (P = 0.02). A large range of intraoperative blood loss (400-7128 mL) was observed, with no significant differences between groups. There were no changes in plasma electrolyte levels or osmolality. Transfusion requirements were similar in both groups. Conclusion: Desmopressin did not reduce intraoperative blood loss or transfusion requirements during hepatectomy despite raising clotting factor levels and improving tests of hemostasis.

Cite

CITATION STYLE

APA

Wong, A. Y. C., Irwin, M. G., Hui, T. W. C., Fung, S. K. Y., Fan, S. T., & Ma, E. S. K. (2003). Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Canadian Journal of Anesthesia, 50(1), 14–20. https://doi.org/10.1007/BF03020180

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free